{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:52:34Z","timestamp":1755219154737,"version":"3.43.0"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,6]]},"DOI":"10.7759\/cureus.89499","type":"journal-article","created":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T19:20:51Z","timestamp":1754508051000},"source":"Crossref","is-referenced-by-count":0,"title":["Cryptosporidium Diarrhea in a Patient With Class IV Lupus Nephritis on Cyclophosphamide: An Underreported Case"],"prefix":"10.7759","author":[{"given":"Neha Sai P","family":"Doddapaneni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saishirini","family":"Yerremreddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Srinivas","family":"Nalabothula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa381","article-title":"Lupus nephritis: clinical presentations and outcomes in the 21st century","volume":"59","author":"Gasparotto M","year":"2020","unstructured":"Gasparotto M, Gatto M, Binda V, Doria A, Moroni G. Lupus nephritis: clinical presentations and outcomes in the 21st century. Rheumatology (Oxford). 2020, 59:v39-51. 10.1093\/rheumatology\/keaa381","journal-title":"Rheumatology (Oxford)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2147\/OARRR.S384256","article-title":"Gastrointestinal manifestations in patients with systemic lupus erythematosus","volume":"14","author":"Alharbi S","year":"2022","unstructured":"Alharbi S. Gastrointestinal manifestations in patients with systemic lupus erythematosus. Open Access Rheumatol. 2022, 14:243-53. 10.2147\/OARRR.S384256","journal-title":"Open Access Rheumatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2009.53","article-title":"Lupus mesenteric vasculitis can cause acute abdominal pain in patients with SLE","volume":"5","author":"Ju JH","year":"2009","unstructured":"Ju JH, Min JK, Jung CK, et al.. Lupus mesenteric vasculitis can cause acute abdominal pain in patients with SLE. Nat Rev Rheumatol. 2009, 5:273-81. 10.1038\/nrrheum.2009.53","journal-title":"Nat Rev Rheumatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v16.i24.2971","article-title":"Gastrointestinal involvement in systemic lupus erythematosus: insight into pathogenesis, diagnosis and treatment","volume":"16","author":"Tian XP","year":"2010","unstructured":"Tian XP, Zhang X. Gastrointestinal involvement in systemic lupus erythematosus: insight into pathogenesis, diagnosis and treatment. World J Gastroenterol. 2010, 16:2971-7. 10.3748\/wjg.v16.i24.2971","journal-title":"World J Gastroenterol"},{"key":"ref5","article-title":"Cryptosporidiosis","author":"Janssen B","year":"2023","unstructured":"Janssen B, Snowden J. Cryptosporidiosis. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2023."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1080\/14787210.2018.1500457","article-title":"Novel treatment strategies and drugs in development for cryptosporidiosis","volume":"16","author":"Chavez MA","year":"2018","unstructured":"Chavez MA, White AC Jr. Novel treatment strategies and drugs in development for cryptosporidiosis. Expert Rev Anti Infect Ther. 2018, 16:655-61. 10.1080\/14787210.2018.1500457","journal-title":"Expert Rev Anti Infect Ther"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpddr.2021.09.001","article-title":"Treatment of human intestinal cryptosporidiosis: a review of published clinical trials","volume":"17","author":"Diptyanusa A","year":"2021","unstructured":"Diptyanusa A, Sari IP. Treatment of human intestinal cryptosporidiosis: a review of published clinical trials. Int J Parasitol Drugs Drug Resist. 2021, 17:128-38. 10.1016\/j.ijpddr.2021.09.001","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1051\/parasite\/2025001","article-title":"Molecular pathogenesis of Cryptosporidium and advancements in therapeutic interventions","volume":"32","author":"Lu Y","year":"2025","unstructured":"Lu Y, Zhang X, Guan Z, et al.. Molecular pathogenesis of Cryptosporidium and advancements in therapeutic interventions. Parasite. 2025, 32:7. 10.1051\/parasite\/2025001","journal-title":"Parasite"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofab610","article-title":"Resolution of cryptosporidiosis in transplant recipients: review of the literature and presentation of a renal transplant patient treated with nitazoxanide, azithromycin, and rifaximin","volume":"9","author":"Tomczak E","year":"2022","unstructured":"Tomczak E, McDougal AN, White AC Jr. Resolution of cryptosporidiosis in transplant recipients: review of the literature and presentation of a renal transplant patient treated with nitazoxanide, azithromycin, and rifaximin. Open Forum Infect Dis. 2022, 9:ofab610. 10.1093\/ofid\/ofab610","journal-title":"Open Forum Infect Dis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1115522","article-title":"Past, current, and potential treatments for cryptosporidiosis in humans and farm animals: a comprehensive review","volume":"13","author":"Khan SM","year":"2023","unstructured":"Khan SM, Witola WH. Past, current, and potential treatments for cryptosporidiosis in humans and farm animals: a comprehensive review. Front Cell Infect Microbiol. 2023, 13:1115522. 10.3389\/fcimb.2023.1115522","journal-title":"Front Cell Infect Microbiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.18103\/mra.v5i3.1084","article-title":"Low incidence of opportunistic infections in lupus patients treated with cyclophosphamide and steroids in a tertiary care setting","volume":"5","author":"Banerjee S","year":"2017","unstructured":"Banerjee S, Biehl A, Ghaderi-Yeganeh M, Manna Z, Hasni S. Low incidence of opportunistic infections in lupus patients treated with cyclophosphamide and steroids in a tertiary care setting. Med Res Arch. 2017, 5:10.18103\/mra.v5i3.1084","journal-title":"Med Res Arch"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/197540-cryptosporidium-diarrhea-in-a-patient-with-class-iv-lupus-nephritis-on-cyclophosphamide-an-underreported-case","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T19:20:52Z","timestamp":1754508052000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/197540-cryptosporidium-diarrhea-in-a-patient-with-class-iv-lupus-nephritis-on-cyclophosphamide-an-underreported-case"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,6]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.89499","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2025,8,6]]}}}